EUVIMEDEUVIMED entdecken
Open Access

Advancing pediatric drug development in South Asia: Current landscape and vision for the future

Rajesh Krishna, Manoj Jadhav, Rama Sivasubramanian, Gangadhar Sunkara, Vikram Gota, Vis Niranjan, Vipin Dhote, Nidhi Sapkal, Nirmala N Rege, Samir Sethi, Bikash Medhi, Nilima Kshirsagar und 1 weitere

Indian Journal of Pharmacology · 2024

DOI: 10.4103/ijp.ijp_396_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmacology, 2024. Verfasst von Rajesh Krishna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Drug Development Solutions, Certara USA, Inc., Princeton, Hillsborough, USA. Hauptthemen laut MEDLINE: Drug Development, Pediatrics. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The manuscript summarizes the outcomes of a one-day conference by the South Asian College of American College of Clinical Pharmacology (SAC-ACCP) in July 2023, at Bhopal. The theme of the conference was “Advancing pediatric drug development in South Asia.” SAC-ACCP organized this event in Bhopal to foster the discipline of clinical pharmacology and to motivate researchers and physicians in the in the central part of India. The conference featured presentations on regional approaches to pediatric drug development in Asia by pediatric scientific experts from the pharmaceutical industry, regulatory agencies, as well as independent consultancies. The speakers highlighted several important aspects of the evolving regulatory landscape in India and proposed numerous actionable steps in acceleration of pediatric drug development. This commentary provides insights from presentations and the panel discussion at this conference and also makes an attempt to connect to similar discussions that occurred at the SAC-ACCP drug development conference in 2017.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentPediatricsHumansChildAsiaIndiaDrug IndustryPharmacology, ClinicalAsia, Southern

Autor:innen und Institutionen

  • Drug Development Solutions, Certara USA, Inc., Princeton, Hillsborough, USA.
  • Clinical Development, ISHA Therapeutics, Hillsborough, USA.
  • Clinical Development, Novartis Healthcare Pvt. Ltd, Hyderabad, India.
  • Development, Novartis Pharmaceuticals, East Hanover, USA.
  • Clinial Pharmacology, Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India.
  • Translational Medicine, RxMD, Chennai, India.

Zitieren

APA

Krishna, R., Jadhav, M., Sivasubramanian, R., Sunkara, G., Gota, V., Niranjan, V., Dhote, V., Sapkal, N., Rege, N. N., Sethi, S., Medhi, B., Kshirsagar, N., & Parmar, D. (2024). Advancing pediatric drug development in South Asia: Current landscape and vision for the future. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_396_24

Vancouver

Krishna R, Jadhav M, Sivasubramanian R, Sunkara G, Gota V, Niranjan V, et al. Advancing pediatric drug development in South Asia: Current landscape and vision for the future. Indian Journal of Pharmacology. 2024. doi:10.4103/ijp.ijp_396_24

BibTeX
@article{Krishna2024,
  author = {Krishna, Rajesh and Jadhav, Manoj and Sivasubramanian, Rama and Sunkara, Gangadhar and Gota, Vikram and Niranjan, Vis and Dhote, Vipin and Sapkal, Nidhi and Rege, Nirmala N and Sethi, Samir and Medhi, Bikash and Kshirsagar, Nilima and Parmar, Deven},
  title = {Advancing pediatric drug development in South Asia: Current landscape and vision for the future},
  journal = {Indian Journal of Pharmacology},
  year = {2024},
  doi = {10.4103/ijp.ijp_396_24}
}
Kostenlos starten →